منابع مشابه
Revisiting clinical trials on glycemic control and cardiovascular risk
The most relevant clinical trials, assessing the role of glycemic control in reducing cardiovascular risk, are examined. The UKPDS was the first to address this issue. More recent trials (ACCORD, ADVANCE and VADT) are controversial and evidences did not support that strict glycemic control (reflected by normal glycated hemoglobin) exclusively is sufficient to reduce cardiovascular risk in compl...
متن کاملDiabetes, Glycemic Control, and Risk of Tuberculosis
OBJECTIVE To examine the association between diabetes, glycemic control, and risk of tuberculosis (TB). RESEARCH DESIGN AND METHODS We conducted a population-based case-control study in Northern Denmark. Cases of active TB were all individuals with a first-time principal hospital diagnosis of TB between 1980 and 2008. Each case subject was matched with up to five population control subjects w...
متن کاملEffect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: a randomized controlled trial.
OBJECTIVE Despite their independent cardiovascular disease (CVD) advantages, effects of α-linolenic acid (ALA), monounsaturated fatty acid (MUFA), and low-glycemic-load (GL) diets have not been assessed in combination. We therefore determined the combined effect of ALA, MUFA, and low GL on glycemic control and CVD risk factors in type 2 diabetes. RESEARCH DESIGN AND METHODS The study was a pa...
متن کاملGlycemic control and cardiovascular disease in a high-risk chronic kidney disease population
There are an estimated 23.8 million people in the USA with diabetes, and 171 million worldwide [101,102]. The impact of diabetes on healthcare costs, mortality and comorbidity seems to be the highest amongst all chronic debilitating diseases. Diabetes is the leading cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the USA, accounting for up to 40% of patients on dialy...
متن کاملA Review of Exenatide: Optimizing Glycemic Control and Associated Cardiovascular Risk Factors in Type 2 Diabetes
Type 2 diabetes mellitus (T2DM) is a well-recognized risk factor for the development of cardiovascular disease. With an increasing prevalence of obesity, this risk has increased further. Management of T2DM in obese patients is particularly challenging as treatment with the majority of glucose-lowering agents results in weight gain. Thus, the development of a therapeutic option which could impro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Medical Association Journal
سال: 2009
ISSN: 0820-3946,1488-2329
DOI: 10.1503/cmaj.090252